Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, March 28, 2024 | Back issues
Courthouse News Service Courthouse News Service

Pharma Fine

Shareholders brought a federal derivative lawsuit against McKesson Corp. and its top executives and directors for the $150 million settlement with the Drug Enforcement Administration announced two weeks ago, for violations of the Controlled Substances Act.

SAN FRANCISCO – Shareholders brought a federal derivative lawsuit against McKesson Corp. and its top executives and directors for the $150 million settlement with the Drug Enforcement Administration announced two weeks ago, for violations of the Controlled Substances Act.

Categories / Securities

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...